![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TOXICOLOGY
Departments of Anesthesia (S.R.W., D.L.H.) and Pharmacology (K.T.S., D.L.H.) and the Medical Scientist Training Program (K.T.S.), The University of Iowa, Iowa City, Iowa; Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin (H.M., L.F.T.); and Department of Anesthesiology and Critical Care, The Johns Hopkins University, Baltimore, Maryland (R.W.H.)
This study investigated three possible mechanisms by which the antinociceptive effects of the µ-opioid receptor (MOR) agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) and the
-opioid receptor (DOR) agonist [D-Ala2,Glu4]-deltorphin (deltorphin II) (DELT), microinjected into the rostral ventromedial medulla (RVM), are enhanced in rats with persistent inflammatory injury. Radioligand binding determined that neither the Bmax nor the Kd values of [3H]DAMGO differed in RVM membranes from rats that received an intraplantar injection of saline or complete Freund's adjuvant (CFA) in one hindpaw 4 h, 4 days, or 2 weeks earlier. Likewise, neither the EC50 nor the Emax value for DAMGO-induced stimulation of guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTP
S) binding differed in the RVM of saline- or CFA-treated rats at any time point. Microinjection of fixed dose combinations of DAMGO and DELT in the RVM of naive rats indicated that these agonists interact synergistically to produce antinociception when DAMGO is present in equal or greater amounts than DELT and, additively, when DELT is the predominant component. Thus, unlike the periphery or spinal cord, potentiation of MOR-mediated antinociception does not entail an increase in MOR number, affinity, or coupling. Rather, the data are concordant with our proposal that potentiation results from a synergistic interaction of exogenous MOR agonist with DOR-preferring enkephalins whose levels are increased in CFA-treated rats (J Neurosci 21:2536–2545, 2001). Virtually no specific [3H]DELT binding nor stimulation of [35S]GTP
S binding by DELT was obtained in RVM membranes from CFA- or saline-treated rats at any time point. The mechanisms responsible for the potentiation of DELT-mediated antinociception remain to be elucidated.
Address correspondence to: Dr. Donna L. Hammond, Department of Anesthesia, The University of Iowa, 200 Hawkins Dr. 6 JCP, Iowa City, IA 52242. E-mail: donna-hammond{at}uiowa.edu
This article has been cited by other articles:
![]() |
G. J. Hathway, S. Koch, L. Low, and M. Fitzgerald The changing balance of brainstem\#8211;spinal cord modulation of pain processing over the first weeks of rat postnatal life J. Physiol., June 15, 2009; 587(12): 2927 - 2935. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maione, K. Starowicz, L. Cristino, F. Guida, E. Palazzo, L. Luongo, F. Rossi, I. Marabese, V. de Novellis, and V. Di Marzo Functional Interaction Between TRPV1 and {micro}-Opioid Receptors in the Descending Antinociceptive Pathway Activates Glutamate Transmission and Induces Analgesia J Neurophysiol, May 1, 2009; 101(5): 2411 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bie, W. Zhu, and Z. Z. Pan Rewarding Morphine-Induced Synaptic Function of {delta}-Opioid Receptors on Central Glutamate Synapses J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 290 - 296. [Abstract] [Full Text] [PDF] |
||||